查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1874358

抗衰老龄化药物：全球市场份额和排名、总收入和需求预测（2025-2031）

Anti-aging Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 161 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球抗衰老龄化药物市场预计在 2024 年达到 110.3 亿美元，预计到 2031 年将达到 239.7 亿美元，2025 年至 2031 年的复合年增长率为 11.9%。

本报告对近期抗衰老药物的关税调整和国际战略应对措施进行了全面评估，包括跨境产业布局、资本配置模式、区域经济相互依存以及供应链重组。

肉毒桿菌注射和填充剂治疗正逐渐成为主流。肉毒桿菌含有纯化的细菌，可以麻痹肌肉，从而帮助减少脸部皱纹和表情纹；而填充剂则含有可以丰盈因老龄化增长而变得稀疏的部位的成分。

抗衰老龄化药物市场受多种强劲因素驱动，其中最显着的是全球人口的快速老化。预计到2050年，65岁以上人口数将达到约15亿至21亿。这项人口结构变化推动了针对心血管疾病、糖尿病、神经退化性疾病、骨质疏鬆症和光老化等与老龄化相关的疾病的治疗方法需求。同时，生物技术领域的突破，例如CRISPR基因编辑、老化细胞清除剂、mTOR抑制剂、NAD+增强剂、再生医学、基因编辑和人工智慧药物研发，正在为新的治疗方法铺平道路。可支配收入的成长，尤其是在新兴市场，以及消费者对健康和美容解决方案日益增长的需求，进一步推动了市场扩张。

然而，该领域仍存在诸多障碍。其中一个关键挑战是研发成本庞大。开发此类药物通常需要多年投资、昂贵的临床试验以及复杂的监管核准流程，总成本往往超过10亿美元。监管的不确定性也是一大障碍。老龄化尚未被正式认定为一种疾病，对与老龄化相关的治疗方法的监管也不明确，导致核准延迟。有限的临床证据、短期试验数据以及安全隐患（例如，仿单标示外用药、副作用和缺乏生物标记）阻碍了此类药物的广泛应用。

本报告旨在对全球抗衰老龄化药物市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名，以及按地区/国家、类型和应用分析抗衰老龄化药物。

抗衰老龄化药物市场规模、估算和预测以销售（千瓶）和收入（百万美元）为单位呈现，基准年为2024年，并包含2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定抗衰老药物的业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • AbbVie
  • Galderma
  • LG Life Sciences
  • Merz
  • Medytox
  • Hugel
  • Croma-Pharma
  • Beijing IMEIK
  • Bloomage Bio
  • Elravie（Humedix）
  • Cleviel（Pharma Research Products）
  • Haohai Biological
  • Teoxane
  • Sinclair
  • Suneva Medical
  • CG Bio
  • SciVision Biotech
  • Prollenium
  • Bohus BioTech
  • Caregen
  • Ipsen
  • LIBP
  • US World Meds
  • Daewoong
  • JETEMA

按类型分類的细分市场

  • 皮肤填充剂
  • 肉毒桿菌毒素
  • 其他的

应用领域

  • 医院
  • 美容院
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Anti-aging Drugs was estimated to be worth US$ 11030 million in 2024 and is forecast to a readjusted size of US$ 23970 million by 2031 with a CAGR of 11.9% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Anti-aging Drugs cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.

The anti-aging drugs market is propelled by several compelling factors. Most notably, the global population is aging rapidly-by 2050, the number of people aged 65 and above is projected to reach around 1.5-2.1 billion. This demographic shift fuels demand for therapies targeting age-related diseases like cardiovascular disorders, diabetes, neurodegenerative conditions, osteoporosis, and skin photoaging . Meanwhile, breakthroughs in biotechnology-spanning CRISPR, senolytics, mTOR inhibitors, NAD+ boosters, regenerative medicine, gene-editing, and AI-enabled drug discovery-are unlocking new therapeutic avenues. Rising disposable incomes, especially in emerging markets, and heightened consumer demand for wellness and aesthetic solutions further support market expansion.

Nevertheless, the sector faces significant hurdles. Chief among them are the exorbitant research and R&D costs-developing these drugs typically involves multi-year investment, expensive clinical trials, and complex regulatory approval procedures, often costing upwards of $1 billion . Regulatory ambiguity is another barrier: aging is not formally recognized as a disease, and oversight for aging-related therapies remains unclear, delaying approvals . Limited clinical evidence, short-term trial data, and safety concerns (e.g., off-label use, side effects, lack of biomarkers) hinder adoption

This report aims to provide a comprehensive presentation of the global market for Anti-aging Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-aging Drugs by region & country, by Type, and by Application.

The Anti-aging Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-aging Drugs.

Market Segmentation

By Company

  • AbbVie
  • Galderma
  • LG Life Sciences
  • Merz
  • Medytox
  • Hugel
  • Croma-Pharma
  • Beijing IMEIK
  • Bloomage Bio
  • Elravie (Humedix)
  • Cleviel (Pharma Research Products)
  • Haohai Biological
  • Teoxane
  • Sinclair
  • Suneva Medical
  • CG Bio
  • SciVision Biotech
  • Prollenium
  • Bohus BioTech
  • Caregen
  • Ipsen
  • LIBP
  • US World Meds
  • Daewoong
  • JETEMA

Segment by Type

  • Dermal Fillers
  • Botulinum Toxin
  • Others

Segment by Application

  • Hospital
  • Beauty Parlor
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Anti-aging Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Anti-aging Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Anti-aging Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Anti-aging Drugs Product Introduction
  • 1.2 Global Anti-aging Drugs Market Size Forecast
    • 1.2.1 Global Anti-aging Drugs Sales Value (2020-2031)
    • 1.2.2 Global Anti-aging Drugs Sales Volume (2020-2031)
    • 1.2.3 Global Anti-aging Drugs Sales Price (2020-2031)
  • 1.3 Anti-aging Drugs Market Trends & Drivers
    • 1.3.1 Anti-aging Drugs Industry Trends
    • 1.3.2 Anti-aging Drugs Market Drivers & Opportunity
    • 1.3.3 Anti-aging Drugs Market Challenges
    • 1.3.4 Anti-aging Drugs Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Anti-aging Drugs Players Revenue Ranking (2024)
  • 2.2 Global Anti-aging Drugs Revenue by Company (2020-2025)
  • 2.3 Global Anti-aging Drugs Players Sales Volume Ranking (2024)
  • 2.4 Global Anti-aging Drugs Sales Volume by Company Players (2020-2025)
  • 2.5 Global Anti-aging Drugs Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Anti-aging Drugs Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Anti-aging Drugs Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Anti-aging Drugs
  • 2.9 Anti-aging Drugs Market Competitive Analysis
    • 2.9.1 Anti-aging Drugs Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Anti-aging Drugs Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Dermal Fillers
    • 3.1.2 Botulinum Toxin
    • 3.1.3 Others
  • 3.2 Global Anti-aging Drugs Sales Value by Type
    • 3.2.1 Global Anti-aging Drugs Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Anti-aging Drugs Sales Value, by Type (2020-2031)
    • 3.2.3 Global Anti-aging Drugs Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Anti-aging Drugs Sales Volume by Type
    • 3.3.1 Global Anti-aging Drugs Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Anti-aging Drugs Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Anti-aging Drugs Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Anti-aging Drugs Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Beauty Parlor
    • 4.1.3 Others
  • 4.2 Global Anti-aging Drugs Sales Value by Application
    • 4.2.1 Global Anti-aging Drugs Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Anti-aging Drugs Sales Value, by Application (2020-2031)
    • 4.2.3 Global Anti-aging Drugs Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Anti-aging Drugs Sales Volume by Application
    • 4.3.1 Global Anti-aging Drugs Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Anti-aging Drugs Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Anti-aging Drugs Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Anti-aging Drugs Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Anti-aging Drugs Sales Value by Region
    • 5.1.1 Global Anti-aging Drugs Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Anti-aging Drugs Sales Value by Region (2020-2025)
    • 5.1.3 Global Anti-aging Drugs Sales Value by Region (2026-2031)
    • 5.1.4 Global Anti-aging Drugs Sales Value by Region (%), (2020-2031)
  • 5.2 Global Anti-aging Drugs Sales Volume by Region
    • 5.2.1 Global Anti-aging Drugs Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Anti-aging Drugs Sales Volume by Region (2020-2025)
    • 5.2.3 Global Anti-aging Drugs Sales Volume by Region (2026-2031)
    • 5.2.4 Global Anti-aging Drugs Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Anti-aging Drugs Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Anti-aging Drugs Sales Value, 2020-2031
    • 5.4.2 North America Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Anti-aging Drugs Sales Value, 2020-2031
    • 5.5.2 Europe Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Anti-aging Drugs Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Anti-aging Drugs Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Anti-aging Drugs Sales Value, 2020-2031
    • 5.7.2 South America Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Anti-aging Drugs Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Anti-aging Drugs Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Anti-aging Drugs Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Anti-aging Drugs Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Anti-aging Drugs Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Anti-aging Drugs Sales Value, 2020-2031
    • 6.3.2 United States Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Anti-aging Drugs Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Anti-aging Drugs Sales Value, 2020-2031
    • 6.4.2 Europe Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Anti-aging Drugs Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Anti-aging Drugs Sales Value, 2020-2031
    • 6.5.2 China Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Anti-aging Drugs Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Anti-aging Drugs Sales Value, 2020-2031
    • 6.6.2 Japan Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Anti-aging Drugs Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Anti-aging Drugs Sales Value, 2020-2031
    • 6.7.2 South Korea Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Anti-aging Drugs Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Anti-aging Drugs Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Anti-aging Drugs Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Anti-aging Drugs Sales Value, 2020-2031
    • 6.9.2 India Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Anti-aging Drugs Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 AbbVie
    • 7.1.1 AbbVie Company Information
    • 7.1.2 AbbVie Introduction and Business Overview
    • 7.1.3 AbbVie Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 AbbVie Anti-aging Drugs Product Offerings
    • 7.1.5 AbbVie Recent Development
  • 7.2 Galderma
    • 7.2.1 Galderma Company Information
    • 7.2.2 Galderma Introduction and Business Overview
    • 7.2.3 Galderma Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Galderma Anti-aging Drugs Product Offerings
    • 7.2.5 Galderma Recent Development
  • 7.3 LG Life Sciences
    • 7.3.1 LG Life Sciences Company Information
    • 7.3.2 LG Life Sciences Introduction and Business Overview
    • 7.3.3 LG Life Sciences Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 LG Life Sciences Anti-aging Drugs Product Offerings
    • 7.3.5 LG Life Sciences Recent Development
  • 7.4 Merz
    • 7.4.1 Merz Company Information
    • 7.4.2 Merz Introduction and Business Overview
    • 7.4.3 Merz Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Merz Anti-aging Drugs Product Offerings
    • 7.4.5 Merz Recent Development
  • 7.5 Medytox
    • 7.5.1 Medytox Company Information
    • 7.5.2 Medytox Introduction and Business Overview
    • 7.5.3 Medytox Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Medytox Anti-aging Drugs Product Offerings
    • 7.5.5 Medytox Recent Development
  • 7.6 Hugel
    • 7.6.1 Hugel Company Information
    • 7.6.2 Hugel Introduction and Business Overview
    • 7.6.3 Hugel Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Hugel Anti-aging Drugs Product Offerings
    • 7.6.5 Hugel Recent Development
  • 7.7 Croma-Pharma
    • 7.7.1 Croma-Pharma Company Information
    • 7.7.2 Croma-Pharma Introduction and Business Overview
    • 7.7.3 Croma-Pharma Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Croma-Pharma Anti-aging Drugs Product Offerings
    • 7.7.5 Croma-Pharma Recent Development
  • 7.8 Beijing IMEIK
    • 7.8.1 Beijing IMEIK Company Information
    • 7.8.2 Beijing IMEIK Introduction and Business Overview
    • 7.8.3 Beijing IMEIK Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Beijing IMEIK Anti-aging Drugs Product Offerings
    • 7.8.5 Beijing IMEIK Recent Development
  • 7.9 Bloomage Bio
    • 7.9.1 Bloomage Bio Company Information
    • 7.9.2 Bloomage Bio Introduction and Business Overview
    • 7.9.3 Bloomage Bio Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Bloomage Bio Anti-aging Drugs Product Offerings
    • 7.9.5 Bloomage Bio Recent Development
  • 7.10 Elravie (Humedix)
    • 7.10.1 Elravie (Humedix) Company Information
    • 7.10.2 Elravie (Humedix) Introduction and Business Overview
    • 7.10.3 Elravie (Humedix) Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Elravie (Humedix) Anti-aging Drugs Product Offerings
    • 7.10.5 Elravie (Humedix) Recent Development
  • 7.11 Cleviel (Pharma Research Products)
    • 7.11.1 Cleviel (Pharma Research Products) Company Information
    • 7.11.2 Cleviel (Pharma Research Products) Introduction and Business Overview
    • 7.11.3 Cleviel (Pharma Research Products) Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Cleviel (Pharma Research Products) Anti-aging Drugs Product Offerings
    • 7.11.5 Cleviel (Pharma Research Products) Recent Development
  • 7.12 Haohai Biological
    • 7.12.1 Haohai Biological Company Information
    • 7.12.2 Haohai Biological Introduction and Business Overview
    • 7.12.3 Haohai Biological Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Haohai Biological Anti-aging Drugs Product Offerings
    • 7.12.5 Haohai Biological Recent Development
  • 7.13 Teoxane
    • 7.13.1 Teoxane Company Information
    • 7.13.2 Teoxane Introduction and Business Overview
    • 7.13.3 Teoxane Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Teoxane Anti-aging Drugs Product Offerings
    • 7.13.5 Teoxane Recent Development
  • 7.14 Sinclair
    • 7.14.1 Sinclair Company Information
    • 7.14.2 Sinclair Introduction and Business Overview
    • 7.14.3 Sinclair Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Sinclair Anti-aging Drugs Product Offerings
    • 7.14.5 Sinclair Recent Development
  • 7.15 Suneva Medical
    • 7.15.1 Suneva Medical Company Information
    • 7.15.2 Suneva Medical Introduction and Business Overview
    • 7.15.3 Suneva Medical Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Suneva Medical Anti-aging Drugs Product Offerings
    • 7.15.5 Suneva Medical Recent Development
  • 7.16 CG Bio
    • 7.16.1 CG Bio Company Information
    • 7.16.2 CG Bio Introduction and Business Overview
    • 7.16.3 CG Bio Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 CG Bio Anti-aging Drugs Product Offerings
    • 7.16.5 CG Bio Recent Development
  • 7.17 SciVision Biotech
    • 7.17.1 SciVision Biotech Company Information
    • 7.17.2 SciVision Biotech Introduction and Business Overview
    • 7.17.3 SciVision Biotech Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 SciVision Biotech Anti-aging Drugs Product Offerings
    • 7.17.5 SciVision Biotech Recent Development
  • 7.18 Prollenium
    • 7.18.1 Prollenium Company Information
    • 7.18.2 Prollenium Introduction and Business Overview
    • 7.18.3 Prollenium Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 Prollenium Anti-aging Drugs Product Offerings
    • 7.18.5 Prollenium Recent Development
  • 7.19 Bohus BioTech
    • 7.19.1 Bohus BioTech Company Information
    • 7.19.2 Bohus BioTech Introduction and Business Overview
    • 7.19.3 Bohus BioTech Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Bohus BioTech Anti-aging Drugs Product Offerings
    • 7.19.5 Bohus BioTech Recent Development
  • 7.20 Caregen
    • 7.20.1 Caregen Company Information
    • 7.20.2 Caregen Introduction and Business Overview
    • 7.20.3 Caregen Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Caregen Anti-aging Drugs Product Offerings
    • 7.20.5 Caregen Recent Development
  • 7.21 Ipsen
    • 7.21.1 Ipsen Company Information
    • 7.21.2 Ipsen Introduction and Business Overview
    • 7.21.3 Ipsen Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.21.4 Ipsen Anti-aging Drugs Product Offerings
    • 7.21.5 Ipsen Recent Development
  • 7.22 LIBP
    • 7.22.1 LIBP Company Information
    • 7.22.2 LIBP Introduction and Business Overview
    • 7.22.3 LIBP Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.22.4 LIBP Anti-aging Drugs Product Offerings
    • 7.22.5 LIBP Recent Development
  • 7.23 US World Meds
    • 7.23.1 US World Meds Company Information
    • 7.23.2 US World Meds Introduction and Business Overview
    • 7.23.3 US World Meds Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.23.4 US World Meds Anti-aging Drugs Product Offerings
    • 7.23.5 US World Meds Recent Development
  • 7.24 Daewoong
    • 7.24.1 Daewoong Company Information
    • 7.24.2 Daewoong Introduction and Business Overview
    • 7.24.3 Daewoong Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.24.4 Daewoong Anti-aging Drugs Product Offerings
    • 7.24.5 Daewoong Recent Development
  • 7.25 JETEMA
    • 7.25.1 JETEMA Company Information
    • 7.25.2 JETEMA Introduction and Business Overview
    • 7.25.3 JETEMA Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.25.4 JETEMA Anti-aging Drugs Product Offerings
    • 7.25.5 JETEMA Recent Development

8 Industry Chain Analysis

  • 8.1 Anti-aging Drugs Industrial Chain
  • 8.2 Anti-aging Drugs Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Anti-aging Drugs Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Anti-aging Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Anti-aging Drugs Market Trends
  • Table 2. Anti-aging Drugs Market Drivers & Opportunity
  • Table 3. Anti-aging Drugs Market Challenges
  • Table 4. Anti-aging Drugs Market Restraints
  • Table 5. Global Anti-aging Drugs Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Anti-aging Drugs Revenue Market Share by Company (2020-2025)
  • Table 7. Global Anti-aging Drugs Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Anti-aging Drugs Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Anti-aging Drugs Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Anti-aging Drugs Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Anti-aging Drugs Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Anti-aging Drugs
  • Table 13. Global Anti-aging Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Anti-aging Drugs Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Anti-aging Drugs Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Anti-aging Drugs Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Anti-aging Drugs Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Anti-aging Drugs Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Anti-aging Drugs Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Anti-aging Drugs Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Anti-aging Drugs Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Anti-aging Drugs Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Anti-aging Drugs Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Anti-aging Drugs Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Anti-aging Drugs Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Anti-aging Drugs Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Anti-aging Drugs Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Anti-aging Drugs Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Anti-aging Drugs Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Anti-aging Drugs Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Anti-aging Drugs Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Anti-aging Drugs Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Anti-aging Drugs Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Anti-aging Drugs Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Anti-aging Drugs Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Anti-aging Drugs Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Anti-aging Drugs Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Anti-aging Drugs Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Anti-aging Drugs Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Anti-aging Drugs Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Anti-aging Drugs Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Anti-aging Drugs Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Anti-aging Drugs Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Anti-aging Drugs Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Anti-aging Drugs Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Anti-aging Drugs Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Anti-aging Drugs Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Anti-aging Drugs Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Anti-aging Drugs Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Anti-aging Drugs Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Anti-aging Drugs Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Anti-aging Drugs Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Anti-aging Drugs Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Anti-aging Drugs Sales Volume, (2026-2031) & (K Units)
  • Table 57. AbbVie Company Information
  • Table 58. AbbVie Introduction and Business Overview
  • Table 59. AbbVie Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. AbbVie Anti-aging Drugs Product Offerings
  • Table 61. AbbVie Recent Development
  • Table 62. Galderma Company Information
  • Table 63. Galderma Introduction and Business Overview
  • Table 64. Galderma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Galderma Anti-aging Drugs Product Offerings
  • Table 66. Galderma Recent Development
  • Table 67. LG Life Sciences Company Information
  • Table 68. LG Life Sciences Introduction and Business Overview
  • Table 69. LG Life Sciences Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. LG Life Sciences Anti-aging Drugs Product Offerings
  • Table 71. LG Life Sciences Recent Development
  • Table 72. Merz Company Information
  • Table 73. Merz Introduction and Business Overview
  • Table 74. Merz Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Merz Anti-aging Drugs Product Offerings
  • Table 76. Merz Recent Development
  • Table 77. Medytox Company Information
  • Table 78. Medytox Introduction and Business Overview
  • Table 79. Medytox Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Medytox Anti-aging Drugs Product Offerings
  • Table 81. Medytox Recent Development
  • Table 82. Hugel Company Information
  • Table 83. Hugel Introduction and Business Overview
  • Table 84. Hugel Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Hugel Anti-aging Drugs Product Offerings
  • Table 86. Hugel Recent Development
  • Table 87. Croma-Pharma Company Information
  • Table 88. Croma-Pharma Introduction and Business Overview
  • Table 89. Croma-Pharma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Croma-Pharma Anti-aging Drugs Product Offerings
  • Table 91. Croma-Pharma Recent Development
  • Table 92. Beijing IMEIK Company Information
  • Table 93. Beijing IMEIK Introduction and Business Overview
  • Table 94. Beijing IMEIK Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. Beijing IMEIK Anti-aging Drugs Product Offerings
  • Table 96. Beijing IMEIK Recent Development
  • Table 97. Bloomage Bio Company Information
  • Table 98. Bloomage Bio Introduction and Business Overview
  • Table 99. Bloomage Bio Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 100. Bloomage Bio Anti-aging Drugs Product Offerings
  • Table 101. Bloomage Bio Recent Development
  • Table 102. Elravie (Humedix) Company Information
  • Table 103. Elravie (Humedix) Introduction and Business Overview
  • Table 104. Elravie (Humedix) Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 105. Elravie (Humedix) Anti-aging Drugs Product Offerings
  • Table 106. Elravie (Humedix) Recent Development
  • Table 107. Cleviel (Pharma Research Products) Company Information
  • Table 108. Cleviel (Pharma Research Products) Introduction and Business Overview
  • Table 109. Cleviel (Pharma Research Products) Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 110. Cleviel (Pharma Research Products) Anti-aging Drugs Product Offerings
  • Table 111. Cleviel (Pharma Research Products) Recent Development
  • Table 112. Haohai Biological Company Information
  • Table 113. Haohai Biological Introduction and Business Overview
  • Table 114. Haohai Biological Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 115. Haohai Biological Anti-aging Drugs Product Offerings
  • Table 116. Haohai Biological Recent Development
  • Table 117. Teoxane Company Information
  • Table 118. Teoxane Introduction and Business Overview
  • Table 119. Teoxane Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 120. Teoxane Anti-aging Drugs Product Offerings
  • Table 121. Teoxane Recent Development
  • Table 122. Sinclair Company Information
  • Table 123. Sinclair Introduction and Business Overview
  • Table 124. Sinclair Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 125. Sinclair Anti-aging Drugs Product Offerings
  • Table 126. Sinclair Recent Development
  • Table 127. Suneva Medical Company Information
  • Table 128. Suneva Medical Introduction and Business Overview
  • Table 129. Suneva Medical Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 130. Suneva Medical Anti-aging Drugs Product Offerings
  • Table 131. Suneva Medical Recent Development
  • Table 132. CG Bio Company Information
  • Table 133. CG Bio Introduction and Business Overview
  • Table 134. CG Bio Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 135. CG Bio Anti-aging Drugs Product Offerings
  • Table 136. CG Bio Recent Development
  • Table 137. SciVision Biotech Company Information
  • Table 138. SciVision Biotech Introduction and Business Overview
  • Table 139. SciVision Biotech Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 140. SciVision Biotech Anti-aging Drugs Product Offerings
  • Table 141. SciVision Biotech Recent Development
  • Table 142. Prollenium Company Information
  • Table 143. Prollenium Introduction and Business Overview
  • Table 144. Prollenium Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 145. Prollenium Anti-aging Drugs Product Offerings
  • Table 146. Prollenium Recent Development
  • Table 147. Bohus BioTech Company Information
  • Table 148. Bohus BioTech Introduction and Business Overview
  • Table 149. Bohus BioTech Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 150. Bohus BioTech Anti-aging Drugs Product Offerings
  • Table 151. Bohus BioTech Recent Development
  • Table 152. Caregen Company Information
  • Table 153. Caregen Introduction and Business Overview
  • Table 154. Caregen Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 155. Caregen Anti-aging Drugs Product Offerings
  • Table 156. Caregen Recent Development
  • Table 157. Ipsen Company Information
  • Table 158. Ipsen Introduction and Business Overview
  • Table 159. Ipsen Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 160. Ipsen Anti-aging Drugs Product Offerings
  • Table 161. Ipsen Recent Development
  • Table 162. LIBP Company Information
  • Table 163. LIBP Introduction and Business Overview
  • Table 164. LIBP Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 165. LIBP Anti-aging Drugs Product Offerings
  • Table 166. LIBP Recent Development
  • Table 167. US World Meds Company Information
  • Table 168. US World Meds Introduction and Business Overview
  • Table 169. US World Meds Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 170. US World Meds Anti-aging Drugs Product Offerings
  • Table 171. US World Meds Recent Development
  • Table 172. Daewoong Company Information
  • Table 173. Daewoong Introduction and Business Overview
  • Table 174. Daewoong Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 175. Daewoong Anti-aging Drugs Product Offerings
  • Table 176. Daewoong Recent Development
  • Table 177. JETEMA Company Information
  • Table 178. JETEMA Introduction and Business Overview
  • Table 179. JETEMA Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 180. JETEMA Anti-aging Drugs Product Offerings
  • Table 181. JETEMA Recent Development
  • Table 182. Key Raw Materials Lists
  • Table 183. Raw Materials Key Suppliers Lists
  • Table 184. Anti-aging Drugs Downstream Customers
  • Table 185. Anti-aging Drugs Distributors List
  • Table 186. Research Programs/Design for This Report
  • Table 187. Key Data Information from Secondary Sources
  • Table 188. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Anti-aging Drugs Product Picture
  • Figure 2. Global Anti-aging Drugs Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Anti-aging Drugs Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Anti-aging Drugs Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Anti-aging Drugs Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Anti-aging Drugs Report Years Considered
  • Figure 7. Global Anti-aging Drugs Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Anti-aging Drugs Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-aging Drugs Revenue in 2024
  • Figure 10. Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Dermal Fillers Picture
  • Figure 12. Botulinum Toxin Picture
  • Figure 13. Others Picture
  • Figure 14. Global Anti-aging Drugs Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Anti-aging Drugs Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Anti-aging Drugs Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 17. Global Anti-aging Drugs Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Anti-aging Drugs Price by Type (2020-2031) & (US$/Unit)
  • Figure 19. Product Picture of Hospital
  • Figure 20. Product Picture of Beauty Parlor
  • Figure 21. Product Picture of Others
  • Figure 22. Global Anti-aging Drugs Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 23. Global Anti-aging Drugs Sales Value Market Share by Application, 2024 & 2031
  • Figure 24. Global Anti-aging Drugs Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 25. Global Anti-aging Drugs Sales Volume Market Share by Application, 2024 & 2031
  • Figure 26. Global Anti-aging Drugs Price by Application (2020-2031) & (US$/Unit)
  • Figure 27. North America Anti-aging Drugs Sales Value (2020-2031) & (US$ Million)
  • Figure 28. North America Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Europe Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Europe Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Asia Pacific Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Asia Pacific Anti-aging Drugs Sales Value by Region (%), 2024 VS 2031
  • Figure 33. South America Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. South America Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Middle East & Africa Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. Middle East & Africa Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Key Countries/Regions Anti-aging Drugs Sales Value (%), (2020-2031)
  • Figure 38. Key Countries/Regions Anti-aging Drugs Sales Volume (%), (2020-2031)
  • Figure 39. United States Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. United States Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • Figure 41. United States Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
  • Figure 42. Europe Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. Europe Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • Figure 44. Europe Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
  • Figure 45. China Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. China Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • Figure 47. China Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
  • Figure 48. Japan Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. Japan Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • Figure 50. Japan Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
  • Figure 51. South Korea Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
  • Figure 52. South Korea Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • Figure 53. South Korea Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
  • Figure 54. Southeast Asia Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
  • Figure 55. Southeast Asia Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • Figure 56. Southeast Asia Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
  • Figure 57. India Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
  • Figure 58. India Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • Figure 59. India Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
  • Figure 60. Anti-aging Drugs Industrial Chain
  • Figure 61. Anti-aging Drugs Manufacturing Cost Structure
  • Figure 62. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 63. Bottom-up and Top-down Approaches for This Report
  • Figure 64. Data Triangulation
  • Figure 65. Key Executives Interviewed